Farther Finance Advisors, LLC Harmony Biosciences Holdings, Inc. Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 129 shares of HRMY stock, worth $4,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129
Previous 224
42.41%
Holding current value
$4,575
Previous $7.26 Million
43.87%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
47.9MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$235 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$181 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$57.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$56.1 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...